Vaccine demonstrates protection against COVID-19 related hospitalization and death, and across different variants.
Professor Roger Seheult, MD discusses the CDC and FDA’s decision to pause administration of the Johnson & Johnson vaccine, as well as variants and vaccine coverage around the world, highlighting COVID-19 surges in Brazil and India and what Israel is doi
The acting head of the US Centers for Medicare and Medicaid Services gave reassurances on 5 April that the Johnson & Johnson vaccine was safe, after a mix-up at a production plant in Maryland ruined 15 million potential doses of the vaccine.1 Andy Slavitt said at a press briefing, "All ...
Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19 Vaccine Company expects 2023 Adjusted Reported Earnings Per Shar...
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older Vaccine demonstrates protection against COVID-19 related hospitalization and death, and across different variants November 24, 20...
The United States has reached something of a turning point in its COVID-19 vaccination campaign, with ten states opening vaccine eligibility to all adults in coming days. This is what the Centers for Disease Control terms Phase 2 of vaccine elig...
Also, they were tested back in the summertime, prior to the emergence of the recently discovered COVID-19 variants. "They did run the vaccine at a period that was simpler," said Mammen. "These variants are particularly tricky as they can be more virulent [and] a little bit harder to p...
The Johnson & Johnson COVID-19 single-shot vaccine is compatible with standard vaccine storage and distribution channels enabling delivery to remote areas.4 The vaccine is estimated to remain stable for two years at -25 to -15°C, and a maximum of three months of which can ...
The Johnson & Johnson Covid-19 vaccine seems to work better than initial data showed against the virus variant first identified in South Africa. The variant, which is thought to be more contagious, currently makes up the majority of cases in South Africa and has been found in several countrie...
Johnson & Johnson’s Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% effective against severe disease, the company announced Friday. The vaccine was 72% effective against moderate and severe disease in ...